Editorial: Cardiometabolic criteria matters in MASLD

Margaret L P Teng¹, Mark D Muthiah^{1

2

3}, Daniel Q Huang^{1

2

3}

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore, Singapore.
² National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore.
³ Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Editorial

Margaret L P Teng et al. Aliment Pharmacol Ther. 2024 Oct.

. 2024 Oct;60(8):1126-1127.

doi: 10.1111/apt.18233. Epub 2024 Sep 3.

Margaret L P Teng¹, Mark D Muthiah^{1

2

3}, Daniel Q Huang^{1

2

3}

¹ Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore, Singapore.
² National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore.
³ Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

No abstract available

References

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–2752.
1. Huang DQ, Fowler KJ, Liau J, Cunha GM, Louie AL, An JY, et al. Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: a prospective study. Aliment Pharmacol Ther. 2022;55(7):820–827.
1. Tamaki N, Kimura T, Wakabayashi S‐I, Umemura T, Izumi N, Loomba R, et al. Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease. Aliment Pharmacol Ther. 2024;60:1033–1041.
1. Mellemkjær A, Kjær MB, Haldrup D, Grønbæk H, Thomsen KL. Management of cardiovascular risk in patients with metabolic dysfunction‐associated steatotic liver disease. Eur J Intern Med. 2023;122:28–34.
1. Kanwal F, Kramer JR, Li L, Dai J, Natarajan Y, Yu X, et al. Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease. Hepatology. 2020;71(3):808–819.